What is the evidence base for heart failure pharmacotherapies in people with severe Chronic Kidney Disease (CKD)?
People with severe CKD (eGFR<30 ml/min/1.73 m2 ) have largely been excluded from key randomised controlled trials of heart failure pharmacotherapies, and the evidence base for such therapies in this important subgroup has therefore been lacking and clinical practice inconsistent.